Format

Send to

Choose Destination
Rev Urol. 2008 Summer;10(3):192-206.

Nutraceuticals in Prostate Disease: The Urologist's Role.

Abstract

Interest in and use of complementary and alternative therapies, especially nutraceuticals, is high in prostate disease. These therapies have shown potential in benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer. Some have produced results equal to or better than pharmaceuticals currently prescribed for BPH. In category III prostatitis, some nutraceuticals may offer relief to patients who get little from standard therapy. Because it is becoming apparent that inflammation may play a role in the progression of BPH and development of prostate cancer, nutraceuticals, which commonly have anti-inflammatory properties, may play a role. These therapies have also shown potential in prostate cancer treatment and prevention, especially those that also reduce cardiovascular events or risk. Nevertheless, uses of some nutraceuticals in prostate disease have had less desirable consequences, showing lack of efficacy, adulteration, and/or severe side effects or drug interactions. By ensuring that these therapies undergo careful study for effectiveness, quality, and safety, urologists can look forward to adding them to their evidence-based armamentarium for prostate disease.

KEYWORDS:

Benign prostatic hyperplasia; Complementary or alternative medical therapy; Nutraceuticals; Prostate cancer; Prostatitis

PMID:
18836556
PMCID:
PMC2556486

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center